In ALK fusion‐positive NSCLC, novel variant ALK fusions (e.g., non–EML4‐ALK fusions) are increasingly being identified alongside the canonical EML4‐ALK fusion [10]. This evidence concerns the gene ALK and non-small cell lung carcinoma.